glp 1 australia Weight loss drugs Australia: Half a million use Ozempic and Mounjaro monthly, UNSW study reveals TGA issues warning over GLP-1-based

Gentle, wall-directed addition protects the peptide structure

Sisson says

It will be important to watch the progress of these cases

It is also hard to predict how people will think about these drugs over the long term, with a recent study by The New Consumer and Coefficient Capital showing that 46% of 1,810 consumers aware of GLP-1 weight loss drugs are extremely or very concerned about their long-term health impact, a figure that rises to 51% among users of such drugs (n-388)

The transition toward oral delivery will be evolutionary, not disruptive, dependent on regulatory approvals, proven equivalence in cardiovascular outcomes, and competitive pricing